Wells Fargo’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $410K | Sell |
41,302
-15,821
| -28% | -$157K | ﹤0.01% | 3920 |
|
2025
Q1 | $542K | Buy |
57,123
+17,632
| +45% | +$167K | ﹤0.01% | 3623 |
|
2024
Q4 | $545K | Sell |
39,491
-4,641
| -11% | -$64K | ﹤0.01% | 3664 |
|
2024
Q3 | $671K | Sell |
44,132
-814
| -2% | -$12.4K | ﹤0.01% | 3452 |
|
2024
Q2 | $214K | Buy |
44,946
+12,384
| +38% | +$59.1K | ﹤0.01% | 4123 |
|
2024
Q1 | $221K | Buy |
32,562
+32,326
| +13,697% | +$219K | ﹤0.01% | 4048 |
|
2023
Q4 | $1.15K | Buy |
236
+48
| +26% | +$235 | ﹤0.01% | 5749 |
|
2023
Q3 | $643 | Sell |
188
-994
| -84% | -$3.4K | ﹤0.01% | 5931 |
|
2023
Q2 | $5.65K | Buy |
1,182
+7
| +0.6% | +$33 | ﹤0.01% | 5749 |
|
2023
Q1 | $4.96K | Buy |
1,175
+1,003
| +583% | +$4.23K | ﹤0.01% | 5738 |
|
2022
Q4 | $664 | Buy |
172
+10
| +6% | +$39 | ﹤0.01% | 5976 |
|
2022
Q3 | $1K | Sell |
162
-1
| -0.6% | -$6 | ﹤0.01% | 5959 |
|
2022
Q2 | $1K | Sell |
163
-986
| -86% | -$6.05K | ﹤0.01% | 6173 |
|
2022
Q1 | $4K | Buy |
1,149
+1
| +0.1% | +$3 | ﹤0.01% | 6156 |
|
2021
Q4 | $3K | Buy |
1,148
+1,008
| +720% | +$2.63K | ﹤0.01% | 6233 |
|
2021
Q3 | $1K | Sell |
140
-7
| -5% | -$50 | ﹤0.01% | 6329 |
|
2021
Q2 | $1K | Buy |
147
+14
| +11% | +$95 | ﹤0.01% | 6282 |
|
2021
Q1 | $1K | Hold |
133
| – | – | ﹤0.01% | 6315 |
|
2020
Q4 | $0 | Buy |
133
+12
| +10% | – | ﹤0.01% | 6138 |
|
2020
Q3 | $1K | Sell |
121
-2,902
| -96% | -$24K | ﹤0.01% | 5826 |
|
2020
Q2 | $14K | Buy |
3,023
+3,000
| +13,043% | +$13.9K | ﹤0.01% | 5448 |
|
2020
Q1 | $0 | Buy |
+23
| New | – | ﹤0.01% | 5856 |
|
2018
Q1 | – | Sell |
-3,530
| Closed | -$56K | – | 5887 |
|
2017
Q4 | $56K | Hold |
3,530
| – | – | ﹤0.01% | 5240 |
|
2017
Q3 | $107K | Buy |
+3,530
| New | +$107K | ﹤0.01% | 4986 |
|
2015
Q4 | – | Sell |
-1
| Closed | – | – | 5888 |
|
2015
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5886 |
|